Eniola’s research in addiction neuroscience (CCT model), drug resistance (TOPOLOGIX), and computational pharmacology aligns with the **Asia Health Policy Program** or **general contemporary Asia** tracks, particularly if framed around health policy or regional health challenges. However, the programme’s focus on political/economic/social issues in Asia is less directly tied to her neuropharm/ML work, and the lack of explicit neuroscience/health-tech sub-programs reduces the fit. A compelling application would need to bridge her research to Asia-Pacific health policy or regional health disparities.